Effects of supplementation with multivitamin and mineral on blood pressure and C-reactive protein in obese Chinese women with increased cardiovascular disease risk;Chinese Source

Asia Pacific Journal of Clinical Nutrition

Volumn 18, Issue 1, 2009, Pages 121-130

  Wang, Cheng ^a   Li, Ying ^a   Zhu, Kun ^b,c   Dong, Yan Mei ^d   Sun, Chang Hao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d QIQIHAR MEDICAL UNIVERSITY   (China)

Author keywords

Blood pressure; C reactive protein; Chinese; Multivitamin and mineral supplementation; Obesity; Women

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; IRON; MINERAL; RIBOFLAVIN; THIAMINE; VITAMIN; ZINC;

ADOLESCENT; ARTICLE; BLOOD; BLOOD PRESSURE; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; METABOLISM; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; BLOOD PRESSURE; C-REACTIVE PROTEIN; CALCIUM; CHINA; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPERTENSION; IRON; MIDDLE AGED; MINERALS; OBESITY; RIBOFLAVIN; THIAMINE; VITAMINS; ZINC;

EID: 67649986142     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. World Health Organization. Fact sheet: obesity and overweight. Internet: http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/ (accessed 3 January 2005).
2. Li LM, RAO KQ, Kong LZ, Yao CH, Xiang HD, Zhai FY, et al. A description on the Chinese national nutrition and health survey in 2002. Chin J Epidemiol. 2005;26:478-84.
3. Bogers RP, Bemelmans WJ, Hoogenveen RT, Boshuizen HC, Woodward M, Knekt P et al. Association of Overweight With Increased Risk of Coronary Heart Disease Partly Independent of Blood Pressure and Cholesterol Levels: A Meta-analysis of 21 Cohort Studies Including More Than 300000 Persons. Arch Intern Med. 2007;167:1720-8.
4. Zhou B, Wu Y, Yang J, Li Y, Zhang H, Zhao L. Overweight is an independent risk factor for cardiovascular disease in Chinese populations. Obes Rev. 2002;3:147-56.
5. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS et al. Prevalence of obesity, diabetes, and obesityrelated health risk factors, 2001. JAMA. 2003;289:76-9.
6. Roberts WC. Recent studies on the effects of beta-blockers on blood lipid levels. Am Heart J. 1989;117:709-14.
7. Pollare T, Lithell H, Selinus J, Berne C. Sensitivity to insulin during treatment with atenolol and propanolol: a randomized, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. BMJ. 1989; 298:1152-7.
8. Schutte AE, Huisman HW, Oosthuizen W, van Rooyen JM, Jerling JC. Cardiovascular effects of oral Supplementation of vitamin C, E and folic acid in young healthy males. Int J Vitam Nutr Res. 2004;74:285-93.
9. Galley HF, Thornton J, Howdle PD, Walber BE, Webster NR. Combination oral antioxidant supplementation reduces blood pressure. Clin Sci. 1997;92:361-5.
10. Czernichow S, Bertrais S, Blacher J, Galan P, Briançon S, Favier A, et al. Effect of supplementation with antioxidants upon long-term risk of hypertension in the SU.VI.MAX study: association with plasma antioxidant levels. J Hypertens. 2005;23:2013-8.
11. Beyer FR, Dickinson HO, Nicolson DJ, Ford GA, Mason J. Combined calcium, magnesium and potassium supplemenation for the management of primary hypertension in adults. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD004805. DOI:10.1002/14651858.CD004805.pub2.
12. Sacks FM, Brown LE, Appel L, Borhani NO, Evans D, Whelton P. Combinations of potassium, calcium, and magnesium supplements in hypertension. Hypertension. 1995; 26(6 Pt 1):950-6.
13. Hajjar IM, George V, Sasse EA, Kochar MS. A randomized, double-blind, controlled trial of vitamin C in the management of hypertension and lipids. Am J Ther. 2002;9:289-93.
14. Kim MK, Sasaki S, Sasazuki S, Okubo S, Hayashi M, Tsugane S. Lack of long-term effect of vitamin C supplementation on blood pressure. Hypertension. 2002;40:797-803.
15. Yanoff LB, Menzie CM, Denkinger B, Sebring NG, McHugh T, Remaley AT, et al. Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes. 2007;31: 1412-19.
16. De Souza Valente da Silva L, Valeria da Veiga G, Ramalho RA. Association of serum concentrations of retinol and carotenoids with overweight in children and adolescents. Nutrition.2007;23:392-7.
17. Moor DB, Wartanowicz M, Ziemlanski S. Blood vitamin and lipid levels in overweight and obese women. Eur J Clin Nutr. 1992;46:803-8.
18. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690-3.
19. Dakshinamurti K, Lal KJ: Vitamins and hypertension, in Simopoulos AP (ed) Nutrients in the Control of Metabolic Diseases. World Rev Nutr Diet, vol 69. Basal, Karger, 1996. P. 40-73.
20. Singh RB, Niaz MA, Rastogi SS, Bajaj S, Gaoli Z, Shoumin Z. Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr. 1998;17:564-70.
21. Garcia Zozaya JL, Padilla Viloria M. Alterations of calcium, magnesium, and zinc in essential hypertension: Their relation to the renin-angiotensinaldosterone system. Invest Clin. 1997;38:27-40.
22. Tanaka T, Sohmiya K, Kono T, Terasaki F, Horie R, Oh-karu Y, et al. Thiamine attenuates the hypertension and metabolic abnormalities in CD36-defective SHR: uncoupling of glucose oxidation from cellular entry accompanied with enhanced protein O-GlcNAcylation in CD36 deficiency. Mol Cell Biochem. 2007;299(1-2):23-35.
23. Avogaro A, de Kreutzenberg SV. Mechanisms of endothelial dysfunction in obesity. Clin Chim Acta. 2005;360:9-26.
24. Navab M, Gharavi N, Watson AD. Inflammation and metabolic disorders. Curr Opin Clin Nutr Metab Care. 2008;11: 459-64.
25. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006;83:456S-460S.
26. Related Articles, González AS, Guerrero DB, Soto MB, Díaz SP, Martinez-Olmos M et al. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. Eur J Clin Nutr. 2006;60:802-9.
27. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med. 2002;252:283-94.
28. Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Medical Hypotheses. 2004;62:499-506.
29. Coorperative Meta-analysis Group of China Obesity Task Force. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin J Epidemiol. 2002;23:5-10.
30. Cifkova R, Erdine S, Fagard R, Farsang C, Heagerty AM, Kiowski W et al. ESH/ESC Hypertension Guidelines Committee. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens. 2003;21:1779-86
31. C Wang, Y Li, K Zhu, YM Dong and CH Sun 129 2003 ESH/ESC hypertension guidelines. J Hypertens. 2003; 21:1779-86.
32. Willett W. The method of food frequency questionnaire. Willett W, Elizabeth L. The reproducibility and validity of FFQ. In: Willett W. Nutritional Epidemiology. Peking/China. 2006. P.69-142.
33. Chinese Nutrition Society. Chinese Dietary Reference Intakes. Peking/China. 2002. P.46.
34. Johnson CM, Hill CS, Chawla S, Treisman R, Bading H. Calcium controls gene expression via three distinct pathways that can function independently of the Ras/mitogenactivated protein kinases (ERKs) signaling cascade. J Neurosci. 1997;7: 6189-202.
35. Cousins RJ. A role of zinc in the regulation of gene expression. Proceeding of the nutrition society. 1998;57:307-11.
36. Nagpal S, Chandraratna RA. Vitamin A and regulation of gene expression. Curr Opin Clin Nutr Metab Care. 1998;1: 341-6.
37. Azzi A, Gysin R, Kempná P, Munteanu A, Negis Y, Villacorta L et al. Vitamin E mediates cell signaling and regulation of gene expression. Ann N Y Acad Sci. 2004;1031:8695.
38. Zhou C, Fan S, Zhou L, Ni Y, Huang T, Shi Y. Clinical observation of treatment of hypertension with calcium. Am J Hypertens. 1994;7:363-7.
39. Dickinson HO, Nicolson DJ, Cook JV, Campbell F, Beyer FR, Ford GA et al. Calcium supplementation for the management of primary hypertension in adults. Cochrane Data-base of Systematic Reviews 2006, Issue 2. Art. No.: CD004639. DOI:10.1002/14651858.CD004639.pub2.
40. Zemel MB. Calcium Modulation of Hypertension and Obesity: Mechanisms and Implications. J Am Coll Nutr. 2001; 20: 428-35.
41. Farvid MS, Jalali M, Siassi F, Saadat N, Hosseini M. The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes. J Am Coll Nutr. 2004,23:272-9.
42. Ward NC, Wu JH, Clarke MW, Puddey IB, Burke V, Croft KD et al. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J. Hypertens. 2007;25:227-34.
43. Mark SD, Wang W, Fraumeni JF Jr, Li JY, Taylor PR, Wang GQ et al. Lowered risks of hypertension and cerebrovascular disease after vitamin/mineral supplementation: the Linxian Nutrition Intervention Trial. Am J Epidemiol. 1996;143:658-66.
44. Dakshinamurti K, Paulose CS, Viswanathan M. Vitamin B6 and hypertension. Ann N Y Acad Sci. 1990; 575:241-249.
45. Hornig B, Arakawa N, Kohler C, Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation. 1998;97:363-8.
46. Hatton DC, McCarron DA. Dietary calcium and blood pressure in experimental models of hypertension. A review. Hypertension. 1994;4:513-30.
47. Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med. 2003; 24:39-52.
48. Stephensen CB, Gildengorin G. Serum retinol, the acute phase response, and the apparent misclassification of vitamin A status in the third National Health and Nutrition Examination Survey. Am J Clin Nutr. 2000; 72:1170-1178.
49. Friso S, Jacques PF, Wilson PWF, Rosenberg IH, Selhub J. Low circulating vitamin B6 is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation. 2001;103: 2788-91.
50. Wannamethee SG, Lowe GD, Rumley A, Bruckdorfer KR, Whincup PH. Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis. Am J Clin Nutr. 2006;83:567-74.
51. Li JJ, Fang CH, Hui RT. Is hypertension an inflammatory disease? Med Hypotheses. 2005;64:236-40.
52. Church TS, Earnest CP, Wood KA, Kampert JB. Reduction of C-reactive protein levels through use of a multivitamin. Am J Med. 2003;115:702-7.